medigraphic.com

2018, Number 1

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2018; 56 (1)

Laryngeal disease. Endoscopic characterization of 1493 procedures based on age

Che-Morales JL, Figueroa-Hurtado E, Cortes-Télles A

Language: Spanish
References: 22
Page: 38-44
PDF size: 348.82 Kb.


ABSTRACT

Background: Based on international epidemiology, some laryngeal diseases could be more frequent at certain ages. The objective was to describe endoscopic findings in patients through distinct decades of age in a laryngoscopy facility.
Methods: retrospective and descriptive study; clinical and endoscopic records were collected from 1493 procedures performed between 2009 and 2015, and organized in five groups of age for analysis. Differences among them were analyzed by chi squared and ANOVA.
Results: 70% of patients reported dysphonia as a main symptom; 24% of subjects were referred with cancer diagnosis and just 7% of them, showed findings related to malignancy; on the other hand, cancer suspicion increased in direct proportion with age (p ‹ 0.0001); inespecific inflammation and other benign endoscopic manifestations (e.g. vocal fold paralysis, subglotic stenosis and nodules) represented 80% of the whole findings; 14% of the procedures were reported as normal. Glottic and supraglottic structures were the two regions affected by malignancy; this finding was directly related to advanced age, particularly in patients of 70 years of age or older. Finally, subglottic stenosis was observed in patients younger than 50 years of age (p ‹ 0.0001).
Conclusion: Causes of laryngeal diseases are different in individuals according to their age. Carcinoma was more prevalent in adults of 70 years of age or older. Benign causes were secondary to inflammatory and functional conditions


REFERENCES

  1. Schwartz S, Cohen S, Dailey S, Rosenfeld R, Deutsch E, Gillespie M, et al. Clinical Practice Guideline: Hoarseness (Dysphonia). Otolaryngol Head Neck Surg. 2009;141(3 Suppl 2):s1-31.

  2. Paul B, Chen S, Sridharan S, Fang Y, Amin M, Branski R. Diagnostic accuracy of history, laryngoscopy, and stroboscopy. Laryngoscope. 2013;123(1):215-9.

  3. Mau T. Diagnostic Evaluation and Management of Hoarseness. Med Clin N Am. 2010; 94(5):945-60.

  4. Dubal P, Unsal A, Echanique K, Vazquez A, Reder L, Baredes S, et al. Laryngeal Adenosquamous Carcinoma: A population-based perpective. Laryngoscope. 2016:126(4):858-63.

  5. Zhukhovitskaya A, Battaglia D, Khosla S, Murry T, Sulica L. Gender and age in benign vocal fold lesions. Laryngoscope. 2015;125(1):191-6.

  6. Celis-Aguilar EM. Hallazgos endoscópicos asociados con el reflujo faringo-laríngeo en voluntarios asintomáticos y pacientes sintomáticos. Estudio comparativo. An Orl Mex. 2011;56(1):26-36.

  7. Williams J. The Declaration of Helsinki and public health. Bull World Health Organ. 2008;86(8):650-2.

  8. Cohen S, Kim J, Roy N, Asche C, Courey M. Direct health care costs of laryngeal diseases and disorders. Laryngoscope. 2012;122(7):1582-8.

  9. INFOMEX. Número de consultas otorgadas por el servicio de otorrinolaringología de los hospitales generales regionales # 1 (Lic. Ignacio García Téllez) y # 12 (Lic. Benito Juárez) del IMSS Delegación Yucatán en el año 2014-2015. Solicitud de información pública. Folio: 0064102326015.

  10. SINAIS/SINAVE/DGE/SALUD. Perfil Epidemiológico de los tumores malignos en México. Primera Edición, México: Secretaría de Salud. Subsecretaría de Prevención y Promoción de la Salud. Dirección General de Epidemiología; 2011. pp. 13-197.

  11. Herrera-Gómez A, Villavicencio-Valencia V, Rascón- Ortiz M, Luna-Ortiz K. Demografía del cáncer laríngeo en el Instituto Nacional de Cancerología. Cir Ciruj. 2009;77(5):353-7.

  12. Calkovsky V, Wallenfels P, Calkovska A, Hajtman A. Laryngeal cancer: 12-year experience of a single center. United States. Springer International Publishing, 2016.

  13. Gallegos-Hernández J. El cáncer de cabeza y cuello. Factores de riesgo y prevención. Cir Ciruj. 2006; 74(4):287-93.

  14. Cohen S, Kim J, Roy N, Asche C, Courey M. Prevalence and causes of dysphonia in a large treatmentseeking population. Laryngoscope. 2012;122(2): 343-8.

  15. Hogikyan N, Sethuraman G. Validation of an instrument to measure voice-related quality of life (V-RQOL). J Voice. 1999;13(4):557-69.

  16. Behlau M, Madazio G, Oliveira G. Functional dysphonia: strategies to improve patient outcomes. Patient Relat Outcome Meas. 2015;6:243-53.

  17. Remacle M, Lawson G. Diagnosis and management of laryngopharyngeal reflux disease. Curr Opin Otolaryngol Head Neck Surg. 2006;14(3):143-9.

  18. Belafsky P, Postma G, Koufman J. The Validity and Reliability of the Reflux Finding Score (RFS). Laryngoscope. 2001;111(8):1313-7.

  19. Cotton R. Management of subglottic stenosis. Otolaryngol Clin North Am. 2000;33:111-30.

  20. Gustafson M, Hartley B, Cotton R. Acquired total (grade 4) subglottic stenosis in children. Ann Otol Rhinol Laryngol. 2001;110(1):16-9.

  21. Lorente-Ludlow F, Pinedo-Onofre J, Morales-Gómez J, Téllez-Becerra J. Duración de intubación orotraqueal y longitud de estenosis traqueal posintubación, una relación no establecida. Rev Inst Nal Enf Resp Mex. 2008;21(3):181-6.

  22. Che-Morales JL, Díaz-Landero P, Cortés-Télles A. Manejo integral del paciente con traqueostomía. Neumol Cir Torax. 2014;73:254-62.




2020     |     www.medigraphic.com